Your browser doesn't support javascript.
loading
Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis.
De Mutiis, Chiara; Wenderfer, Scott E; Orjuela, Alvaro; Bagga, Arvind; Basu, Biswanath; Sar, Tanmoy; Aggarwal, Amita; Jain, Avinash; Yap, Hui-Kim; Ito, Shuichi; Ohnishi, Ai; Iwata, Naomi; Kasapcopur, Ozgur; Laurent, Audrey; Mastrangelo, Antonio; Ogura, Masao; Shima, Yuko; Rianthavorn, Pornpimol; Silva, Clovis A; Trindade, Vitor; Dormi, Ada; Tullus, Kjell.
Affiliation
  • De Mutiis C; Department of Pediatrics, Maggiore Hospital, Azienda USL, Bologna, Italy.
  • Wenderfer SE; Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Orjuela A; Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Bagga A; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
  • Basu B; Division of Pediatric Nephrology, Department of Pediatrics, Nilratan Sircar Medical College and Hospital, Kolkata.
  • Sar T; Division of Pediatric Nephrology, Department of Pediatrics, Nilratan Sircar Medical College and Hospital, Kolkata.
  • Aggarwal A; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
  • Jain A; Department of Medicine, Sawai Man Singh Medical College, Jaipur, India.
  • Yap HK; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Ito S; Department of Pediatrics, Yokohama City University, Kanazawa-ku, Yokohama.
  • Ohnishi A; Department of Pediatrics, Yokohama City University, Kanazawa-ku, Yokohama.
  • Iwata N; Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan.
  • Kasapcopur O; Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Laurent A; Department of Pediatric Nephrology, Rheumatology and Dermatology, Hospices Civils de Lyon, Lyon, France.
  • Mastrangelo A; Department of Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Maggiore Policlinico Hospital, Milan, Italy.
  • Ogura M; Department of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo.
  • Shima Y; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
  • Rianthavorn P; Division of Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Silva CA; Department of Pediatric Rheumatology, Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Trindade V; Department of Pediatric Rheumatology, Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • Dormi A; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
  • Tullus K; Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Rheumatology (Oxford) ; 61(6): 2563-2571, 2022 05 30.
Article in En | MEDLINE | ID: mdl-34626102
ABSTRACT

OBJECTIVE:

We studied the rate of remission of LN in an international cohort of 248 children and adolescents with biopsy-proven LN. Five different definitions from scientific studies and the definitions recommended by the ACR and Kidney Disease Improving Global Outcomes were used.

METHODS:

Anonymized clinical data in patients with biopsy-proven LN class ≥III (International Society of Nephrology/Royal Pathology Society) diagnosed and treated in the last 10 years in 23 international centres from 10 countries were collected. We compared the rate of patients in complete and partial remission applying the different definitions.

RESULTS:

The mean age at diagnosis was 11 years and 4 months, and 177 were females. The number of patients in complete and partial remission varied a great deal between the different definitions. At 24 months, between 50% and 78.8% of the patients were in full remission as defined by the different criteria. The number of patients in partial remission was low, between 2.3% and 25%. No difference in achieved remission was found between boys and girls or between children and adolescents (P > 0.05). Patients with East Asian ethnicity reached remission more often than other ethnicities (P = 0.03-0.0008). Patients treated in high-income countries showed a higher percentage of complete remission at 12 and 24 months (P = 0.002-0.000001).

CONCLUSION:

The rate of children and adolescents with LN achieving remission varied hugely with the definition used. Our results give important information for long-awaited treatment studies in children and young people.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Kidney Failure, Chronic Type of study: Observational_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Nephritis / Kidney Failure, Chronic Type of study: Observational_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article Affiliation country: Italy